Avasimibe and Sirt 1 Activators Reverse NAFLD and Obesity.

Research output: Contribution to journalEditorial

65 Downloads (Pure)

Abstract

Healthy diets and its therapeutic use in obesity and diabetes may be ineffective with relevance to drug induced mitophagy. Avasimibe and its use with other Sirt 1 activators have become of importance to drug therapy in obesity and diabetes with relevance to the acceleration of hepatic drug metabolism with the prevention of mitochondrial apoptosis. The use of synthetic Sirt 1 activators with healthy diets may prevent brain disease and NAFLD that are associated with the induction of global obesity linked diabetes.
Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalNovel Approaches in Drug Designing & Development
Volume1
Issue number3
Publication statusPublished - 2 Jun 2017

Fingerprint Dive into the research topics of 'Avasimibe and Sirt 1 Activators Reverse NAFLD and Obesity.'. Together they form a unique fingerprint.

  • Cite this